Anders Waage
About
Anders Waage is a scholar working on Hematology, Molecular Biology and Oncology.
According to data from OpenAlex, Anders Waage has authored 179 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Hematology, 81 papers in Molecular Biology and 58 papers in Oncology. Recurrent topics in Anders Waage's work include Multiple Myeloma Research and Treatments (105 papers), Protein Degradation and Inhibitors (24 papers) and Immune Response and Inflammation (20 papers). Anders Waage is often cited by papers focused on Multiple Myeloma Research and Treatments (105 papers), Protein Degradation and Inhibitors (24 papers) and Immune Response and Inflammation (20 papers). Anders Waage collaborates with scholars based in Norway, Denmark and Sweden. Anders Waage's co-authors include Terje Espevik, Alfred Halstensen, Anders Sundan, Magne Børset, P Brandtzæg, Peter Kierulf, Carina Seidel, Henrik Hjorth‐Hansen, Refaat Shalaby and M R Shalaby and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.
In The Last Decade
Anders Waage
171 papers receiving 9.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anders Waage Norway | 49 | 3.5k | 3.0k | 2.9k | 2.4k | 1.5k | 179 | 9.8k | ||
| Zwi Berneman Belgium | 53 | 4.8k 1.4× | 2.3k 0.8× | 4.6k 1.6× | 3.7k 1.5× | 1.1k 0.7× | 320 | 13.2k | ||
| Akihiro Yachie Japan | 50 | 4.4k 1.3× | 2.1k 0.7× | 4.0k 1.4× | 1.4k 0.6× | 1.0k 0.7× | 356 | 10.7k | ||
| Kazuyuki Yoshizaki Japan | 53 | 2.7k 0.8× | 1.9k 0.6× | 4.4k 1.5× | 4.5k 1.9× | 1.0k 0.7× | 143 | 12.2k | ||
| Arndt Borkhardt Germany | 51 | 4.6k 1.3× | 2.8k 0.9× | 1.9k 0.6× | 1.7k 0.7× | 660 0.4× | 342 | 10.2k | ||
| Frank J. T. Staal Netherlands | 55 | 5.6k 1.6× | 1.1k 0.4× | 3.2k 1.1× | 1.6k 0.7× | 801 0.5× | 188 | 11.0k | ||
| Andrew S. Weyrich United States | 70 | 4.1k 1.2× | 4.8k 1.6× | 4.1k 1.4× | 1.9k 0.8× | 1.6k 1.0× | 169 | 15.2k | ||
| Nancy J. Olsen United States | 61 | 2.5k 0.7× | 1.2k 0.4× | 4.8k 1.6× | 1.3k 0.5× | 1.1k 0.7× | 240 | 12.6k | ||
| Karl Welte Germany | 70 | 3.4k 1.0× | 4.3k 1.4× | 7.5k 2.5× | 5.6k 2.4× | 1.5k 1.0× | 382 | 18.6k | ||
| Naoyuki Kamatani Japan | 58 | 5.3k 1.5× | 1.3k 0.4× | 2.5k 0.8× | 2.1k 0.9× | 1.5k 1.0× | 344 | 13.5k | ||
| John H. Kersey United States | 61 | 3.7k 1.1× | 4.4k 1.5× | 3.4k 1.2× | 2.6k 1.1× | 1.2k 0.8× | 207 | 12.8k |
Countries citing papers authored by Anders Waage
Since
Specialization
Citations
This map shows the geographic impact of Anders Waage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Waage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Waage more than expected).
Fields of papers citing papers by Anders Waage
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anders Waage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Waage. The network helps show where Anders Waage may publish in the future.
Co-authorship network of co-authors of Anders Waage
This figure shows the co-authorship network connecting the top 25 collaborators of Anders Waage. A scholar is included among the top collaborators of Anders Waage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Waage. Anders Waage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Slørdahl, Tobias S., Nils Tore Vethe, Henrik Hjorth‐Hansen, et al.. (2025). Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone. eJHaem. 6(1). e1091–e1091.
2.
Abildgaard, Niels, Pekka Anttila, Anders Waage, et al.. (2024). Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries. European Journal of Cancer. 201. 113921–113921.
3.
Misund, Kristine, Davine Hofste op Bruinink, Eivind Coward, et al.. (2022). Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. 36(7). 1887–1897.
4.
Murray, David, Noemí Puig, Sigurður Y. Kristinsson, et al.. (2021). Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood Cancer Journal. 11(2). 24–24.
5.
Ali, Mina, Ram Ajore, Abhishek Niroula, et al.. (2018). The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression. Nature Communications. 9(1). 1649–1649.
6.
Zweegman, Sonja, Pieter Sonneveld, Bronno van der Holt, et al.. (2017). Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial. University of Southern Denmark Research Portal (University of Southern Denmark).
7.
Våtsveen, Thea Kristin, Anne‐Marit Sponaas, Erming Tian, et al.. (2016). Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro. Journal of Hematology & Oncology. 9(1). 75–75.
8.
Donk, Niels W.C.J. van de, Antonio Palumbo, Hans Erik Johnsen, et al.. (2014). The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica. 99(6). 984–996.
9.
Misund, Kristine, Katarzyna Anna Baranowska, Toril Holien, et al.. (2013). A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells. SLAS DISCOVERY. 18(6). 637–646.
10.
Fayers, Peter, Antonio Palumbo, Cyrille Hulin, et al.. (2011). Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood. 118(5). 1239–1247.
11.
Gulbrandsen, Nina, Anders Waage, Peter Gimsing, et al.. (2008). A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity. Lund University Publications (Lund University). 93. 209–209.
12.
Standal, Therese, Henrik Hjorth‐Hansen, Thomas Rasmussen, et al.. (2004). Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.. PubMed. 89(2). 174–82.
13.
Seidel, Carina, Stig Lenhoff, Therese Standal, et al.. (2002). Hepatocyte growth factor in myeloma patients treated with high‐dose chemotherapy. British Journal of Haematology. 119(3). 672–676.
14.
Waage, Anders, Peter Gimsing, Gunnar Juliusson, et al.. (2002). Low serum levels of soluble tumor necrosis factor receptors predict for response to thalidomide in advanced myeloma.. Blood. 100(11). 5082.
15.
Holm, Björn, et al.. (2001). Talassemi og sigdcellesykdom i Norge. Tidsskrift for Den Norske Laegeforening.
16.
Lundbom, Jan, et al.. (2000). The Inflammatory Response Following Treatment of Abdominal Aortic Aneurysms: a Comparison Between Open Surgery and Endovascular Repair. European Journal of Vascular and Endovascular Surgery. 19(5). 536–544.
17.
Børset, Magne, Egil Lien, Terje Espevik, et al.. (1996). Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines. Journal of Biological Chemistry. 271(40). 24655–24661.
18.
Waage, Anders & Sigurd Steinshamn. (1993). Cytokine mediators of septic infections in the normal and granulocytopenic host. European Journal Of Haematology. 50(5). 243–249.
19.
Waage, Anders, Geir Slupphaug, & Refaat Shalaby. (1990). Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts. European Journal of Immunology. 20(11). 2439–2443.
20.
Waage, Anders, Alfred Halstensen, Refaat Shalaby, et al.. (1989). Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.. The Journal of Experimental Medicine. 170(6). 1859–1867.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Zwi Berneman Breakdown of academic impact, for papers by Akihiro Yachie Breakdown of academic impact, for papers by Kazuyuki Yoshizaki Breakdown of academic impact, for papers by Arndt Borkhardt Breakdown of academic impact, for papers by Frank J. T. Staal Breakdown of academic impact, for papers by Andrew S. Weyrich Breakdown of academic impact, for papers by Nancy J. Olsen Breakdown of academic impact, for papers by Karl Welte Breakdown of academic impact, for papers by Naoyuki Kamatani Breakdown of academic impact, for papers by John H. Kersey